Evolution of the concept of biocompatibility and the cardioprotective effect of on-line hemodiafiltration.
Chronic inflammation presented by chronic kidney disease patients is accompanied by an increase in the percentage of CD14+/CD16+ monocytes. The inflammatory activity produced by these cells provokes the activation and death of endothelial cells, which suggests that these cells may play an important role in the coupling of inflammation and endothelial damage in these patients. Therefore, the reduction in CD14+/CD16+ inhibitory monocytes may constitute a therapeutic goal in the treatment of chronic kidney disease patients. The use of the most effective hemodialysis techniques such as on-line hemodiafiltration appears to be a suitable tool for achieving this objective.